• SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax

  • Jan 19 2023
  • Duración: Menos de 1 minuto
  • Podcast

SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax Por arte de portada

SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • David Dodd/GeoVax GeoVax Labs is a clinical-stage biotechnology company developing novel therapies and vaccines for cancers and many of the world's most threatening infectious diseases. The company's lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, presently in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax's […] The post SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax appeared first on Business RadioX ®.
    Más Menos
activate_primeday_promo_in_buybox_DT
Más Menos

Lo que los oyentes dicen sobre SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles